JANX vs. KDP

Last updated Jun 4, 2026

JANX (Janux Therapeutics, Inc.) and KDP (Keurig Dr Pepper Inc.) are both stocks. JANX operates in Biotechnology (Healthcare), while KDP operates in Beverages - Non-Alcoholic (Consumer Defensive). Over the past 3 years, JANX returned -0.20%/yr vs 1.93%/yr for KDP. At a 0.12 correlation, their price movements are largely independent.

Performance

JANX vs. KDP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Janux Therapeutics, Inc. (JANX) and Keurig Dr Pepper Inc. (KDP). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, JANX achieves a -1.52% return, which is significantly lower than KDP's 10.94% return.

JANX

• 1D: -1.38%
• 1M: -5.76%
• YTD: -1.52%
• 6M: -20.57%
• 1Y: -46.56%
• 3Y*: -0.20%
• 5Y*: —
• 10Y*: —

KDP

• 1D: 0.63%
• 1M: 5.82%
• YTD: 10.94%
• 6M: 9.69%
• 1Y: -3.79%
• 3Y*: 1.93%
• 5Y*: -1.19%
• 10Y*: 10.00%

*Multi-year figures are annualized to reflect compound growth (CAGR)

JANX vs. KDP - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
JANX Janux Therapeutics, Inc.	-1.52%	-74.22%	398.97%	-18.53%	-33.25%	-21.55%
KDP Keurig Dr Pepper Inc.	10.94%	-10.14%	-1.05%	-4.24%	-1.23%	5.76%

Correlation

The correlation between JANX and KDP is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.09
Correlation (3Y) Calculated over the trailing 3-year period	0.11
Correlation (All Time) Calculated using the full available price history since Jun 14, 2021	0.12

Fundamentals

Market Cap JANX : $851.63M KDP : $41.66B
EPS JANX : -$1.84 KDP : $1.34
PS Ratio JANX : 39.07 KDP : 2.46
PB Ratio JANX : 0.90 KDP : 2.00
Total Revenue (TTM) JANX : $21.61M KDP : $16.94B
Gross Profit (TTM) JANX : $8.44M KDP : $9.11B
EBITDA (TTM) JANX : -$134.03M KDP : $3.70B

Return for Risk

JANX vs. KDP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

JANX

JANX Risk / Return Rank: 17
JANX Sharpe Ratio Rank: 14
JANX Sortino Ratio Rank: 20
JANX Omega Ratio Rank: 17
JANX Calmar Ratio Rank: 14
JANX Martin Ratio Rank: 17

KDP

KDP Risk / Return Rank: 33
KDP Sharpe Ratio Rank: 35
KDP Sortino Ratio Rank: 30
KDP Omega Ratio Rank: 29
KDP Calmar Ratio Rank: 36
KDP Martin Ratio Rank: 36

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

JANX vs. KDP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Janux Therapeutics, Inc. (JANX) and Keurig Dr Pepper Inc. (KDP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	JANX	KDP	Difference
Sharpe ratio Return per unit of total volatility	-0.63	-0.14	-0.49
Sortino ratio Return per unit of downside risk	-0.43	-0.00	-0.43
Omega ratio Gain probability vs. loss probability	0.92	1.00	-0.08
Calmar ratio Return relative to maximum drawdown	-0.72	-0.14	-0.58
Martin ratio Return relative to average drawdown	-1.10	-0.21	-0.89
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

JANX vs. KDP - Sharpe Ratio Comparison

The current JANX Sharpe Ratio is -0.63, which is lower than the KDP Sharpe Ratio of -0.14. The chart below compares the historical Sharpe Ratios of JANX and KDP, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	JANX	KDP	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.63	-0.14	-0.49
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.06	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.42	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.09	0.56	-0.65

Drawdowns

JANX vs. KDP - Drawdown Comparison

The maximum JANX drawdown since its inception was -83.14%, which is greater than KDP's maximum drawdown of -57.42%. Use the drawdown chart below to compare losses from any high point for JANX and KDP.

Drawdown Indicators

	JANX	KDP	Difference
Max Drawdown Largest peak-to-trough decline	-83.14%	-57.42%	-25.72%
Max Drawdown (1Y) Largest decline over 1 year	-64.94%	-27.48%	-37.46%
Max Drawdown (3Y) Largest decline over 3 years	-81.78%	-30.99%	-50.79%
Max Drawdown (5Y) Largest decline over 5 years	—	-31.20%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-36.87%	—
Current Drawdown Current decline from peak	-79.67%	-15.49%	-64.18%
Average Drawdown Average peak-to-trough decline	-52.01%	-8.57%	-43.44%
Ulcer Index Depth and duration of drawdowns from previous peaks	42.42%	17.80%	+24.62%

Volatility

JANX vs. KDP - Volatility Comparison

Janux Therapeutics, Inc. (JANX) has a higher volatility of 9.11% compared to Keurig Dr Pepper Inc. (KDP) at 4.62%. This indicates that JANX's price experiences larger fluctuations and is considered to be riskier than KDP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	JANX	KDP	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.11%	4.62%	+4.49%
Volatility (6M) Calculated over the trailing 6-month period	82.02%	16.85%	+65.17%
Volatility (1Y) Calculated over the trailing 1-year period	74.22%	27.65%	+46.57%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	131.36%	21.11%	+110.25%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	131.36%	23.85%	+107.51%

Dividends

JANX vs. KDP - Dividend Comparison

JANX has not paid dividends to shareholders, while KDP's dividend yield for the trailing twelve months is around 3.01%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
JANX Janux Therapeutics, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
KDP Keurig Dr Pepper Inc.	3.01%	3.28%	2.72%	2.45%	2.14%	1.83%	1.88%	2.07%	407.49%	2.39%	2.34%	2.06%

Financials

Frequently Asked Questions

Can I hold both JANX and KDP in my portfolio?

JANX and KDP have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, JANX or KDP?

JANX has higher volatility (9.11%) compared to KDP (4.62%). In terms of maximum drawdown, JANX dropped -83.14% vs KDP's -57.42%.

Which has better risk-adjusted returns?

KDP currently has the higher Sharpe Ratio (-0.14 vs -0.63), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.